At that price, MEO better pick up the remaining interest from...

First 3 Last

Share
Profile

Follow
Dr Daz

2,041 Posts.

26/06/15

18:20

Post #: 15538665
Share

Originally posted by staymour ↑

Kea offloading assets, including Puka, as per Notification below on the LSE today.

Sale of Interest in PEP51153

Following an exhaustive marketing exercise conducted on the Company's behalf in the course of the strategic review announced in February 2015, Kea's subsidiary Kea Petroleum Limited has entered into an agreement with Caliera Fund Limited under which Caliera has agreed to acquire KPL's 70% interest in its joint venture with MEO New Zealand Pty Limited regarding PEP51153, the licence which includes the Puka wells and the Shannon prospect. The principal terms of the JV Disposal are as follows:

· Caliera will pay NZ$500,000 (approximately £222,550) for KPL's interest in the JV, payable in cash on completion of the Disposal (less any deposits paid on account as described below);

· Caliera will advance NZ$50,000 (approximately £22,255) against the purchase price provided KPL grants to Caliera as security for the advance a first charge over its assets and an assignment of its interest in the JV. Provided such security is granted Caliera will make further advances to ensure KPL can continue operations prior to completion of the JV Disposal;

· the JV Disposal is conditional upon:

- the waiver by MEO of its pre-emptive rights to acquire KPL's interest in the JV and its consent to KPL giving a first charge over its interest as referred to above;

Expand

At that price, MEO better pick up the remaining interest from KEA!

MEO Price at posting: 1.6¢ Sentiment: Buy Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

NEU

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

NYR

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

CHM

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

There are more pages in this discussion • 36 more messages in this thread...

First 3 Last

Add MEO (ASX) to my watchlist

At that price, MEO better pick up the remaining interest from...

Top Stories

Neuren sees FDA greenlight for 3rd trial into children with Phelan-McDermid syndrome

Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03

Arika to pump $3.2M into gold exploration at WA's Yundamindra following strong maiden program

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Leukaemia patient shows complete response in Chimeric Therapeutics' latest trial

Featured News